We are live on ! Find out more
MD icon

Pediatrix Medical

304 hedge funds and large institutions have $5.49B invested in Pediatrix Medical in 2013 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 104 increasing their positions, 121 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 18

106% more call options, than puts

Call options by funds: $29M | Put options by funds: $14M

10% more funds holding

Funds holding: 276304 (+28)

9% more capital invested

Capital invested by funds: $5.05B → $5.49B (+$437M)

14% less repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 121

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

98.63% less ownership

Funds ownership: 201%102.38% (-99%)

Holders
304
Holders Change
+28
Holders Change %
+10.14%
% of All Funds
8.82%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.15%
New
48
Increased
104
Reduced
121
Closed
18
Calls
$29M
Puts
$14M
Net Calls
+$14.9M
Net Calls Change
+$19.4M
Name Holding Trade Value Shares
Change
Change in
Stake
LSERS
176
Louisiana State Employees Retirement System
Louisiana
$1.47M +$1.48M +27,500 New
WPC
177
White Pine Capital
Minnesota
$1.28M -$451K -8,400 -26%
Citadel Advisors
178
Citadel Advisors
Florida
$1.28M +$1.28M +23,927 New
Fifth Third Bancorp
179
Fifth Third Bancorp
Ohio
$1.26M -$67.2K -1,252 -5%
ICM
180
ICC Capital Management
Florida
$1.19M +$1.19M +22,200 New
JG
181
Jefferies Group
New York
$1.16M +$807K +15,046 +225%
PSUF
182
People's United Financial
Connecticut
$1.15M +$33.2K +618 +3%
SCA
183
SAC Capital Advisors
Connecticut
$1.1M +$1.11M +20,600 New
LG
184
Leuthold Group
Minnesota
$1.09M +$1.1M +20,492 New
EI
185
EAM Investors
California
$1.08M +$16.5K +308 +2%
IGIM
186
I.G. Investment Management
Manitoba, Canada
$1.08M +$65.8K +1,227 +6%
MIU
187
Man Investments (UK)
United Kingdom
$1.08M -$400K -7,461 -27%
PA
188
Profund Advisors
Maryland
$1.07M +$42.5K +791 +4%
IPC
189
Independent Portfolio Consultants
Florida
$1.01M -$268 -5 -0%
Barclays
190
Barclays
United Kingdom
$1.01M +$196K +3,643 +24%
RJA
191
Raymond James & Associates
Florida
$988K +$993K +18,503 New
URS
192
Utah Retirement Systems
Utah
$966K
SCA
193
Secor Capital Advisors
New York
$957K +$962K +17,925 New
SG Americas Securities
194
SG Americas Securities
New York
$939K -$1.28M -23,877 -58%
Neuberger Berman Group
195
Neuberger Berman Group
New York
$853K +$35.2K +655 +4%
AIP
196
Ameritas Investment Partners
Nebraska
$846K -$10.9K -204 -1%
SFP
197
Santa Fe Partners
New Mexico
$839K +$844K +15,725 New
PG
198
PEAK6 Group
Illinois
$822K -$3.68M -68,620 -82%
KeyBank National Association
199
KeyBank National Association
Ohio
$796K -$473K -8,818 -37%
BA
200
BlackRock Advisors
Delaware
$778K +$39.3K +732 +5%

MD Hedge Fund Activity: Q4 2013 in Review

304 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2013, worth a combined $5.49B — up 8.7% from $5.05B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new MD positions and 18 closed out — a net gain of 30 holders — while 104 added to existing stakes and 121 trimmed.

The largest buyer was EARNEST Partners, opening a new position worth an estimated $134M. The largest seller was Fidelity Investments, cutting an estimated $57.1M.

  • 304 institutional investors held Pediatrix Medical (MD) as of Q4 2013, up from 276 in Q3 2013.
  • Funds reported $5.49B of Pediatrix Medical stock for Q4 2013, up 8.7% quarter-over-quarter.
  • 48 funds opened new Pediatrix Medical positions in Q4 2013 and 18 closed out, a net change of +30 holders.
  • The largest Pediatrix Medical buyer in Q4 2013 was EARNEST Partners, an estimated $134M added.
  • The largest Pediatrix Medical seller in Q4 2013 was Fidelity Investments, an estimated $57.1M sold.

Based on aggregated 13F filings for Q4 2013.